Increased expression of chemokine receptor CCR3 and its ligands in ulcerative colitis: The role of colonic epithelial cells in in vitro studies

Clinical and Experimental Immunology

Volumn 162, Issue 2, 2010, Pages 337-347

  Manousou, P ^a   Kolios, G ^b   Valatas, V ^a   Drygiannakis, I ^a   Bourikas, L ^a   Pyrovolaki, K ^a   Koutroubakis, I ^a   Papadaki, H A ^a   Kouroumalis, E ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

CCR3; Chemokines; Eotaxins; IBD; Th cells

Indexed keywords

AZATHIOPRINE; CCL1 CHEMOKINE; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR8; EOTAXIN; EOTAXIN 2; EOTAXIN 3; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INFLIXIMAB; MESALAZINE; RECOMBINANT INTERLEUKIN 1ALPHA; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL CULTURE; CELL FRACTIONATION; CELL ISOLATION; CELL POLARITY; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE DURATION; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; ULCERATIVE COLITIS;

ADULT; ANTIGENS, CD3; CACO-2 CELLS; CHEMOKINE CCL11; CHEMOKINE CCL24; CHEMOKINES, CC; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; CYTOKINES; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; HT29 CELLS; HUMANS; MALE; RECEPTORS, CCR3; T-LYMPHOCYTES;

EID: 78649308209     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04248.x     Document Type: Article

References (45)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347:417-29.
2. Rakoff-Nahoum S, Medzhitov R. Role of the innate immune system and host-commensal mutualism. Curr Top Microbiol Immunol 2006; 308:1-18.
3. Hollander D, Vadheim CM, Brettholz E, Petersen GM, Delahunty T, Rotter JI. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med 1986; 105:883-5.
4. Gitter AH, Wullstein F, Fromm M, Schulzke JD. Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology 2001; 121:1320-8.
5. Neuman MG. Immune dysfunction in inflammatory. Bowel Disease Transl Res 2007; 149:173-86.
6. Kolios G, Rooney N, Murphy CT, Robertson DA, Westwick J. Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines. Gut 1998; 43:56-63.
7. Mudter J, Neurath MF. Mucosal T cells: mediators or guardians of inflammatory bowel disease? Curr Opin Gastroenterol 2003; 19:343-9.
8. Daig R, Andus T, Aschenbrenner E, Falk W, Scholmerich J, Gross V. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 1996; 38:216-22.
9. Z'Graggen K,Walz A,Mazzucchelli L, Strieter RM,Mueller C. The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease. Gastroenterology 1997; 113:808-16.
10. Reinecker HC, Loh EY, Ringler DJ, Mehta A, Rombeau JL, Mac-Dermott RP.Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology 1995; 108:40-50.
11. Sallusto F, Lenig D,Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998; 187:875-83.
12. Zingoni A, Soto H,Hedrick JA et al. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol 1998; 161:547-51.
13. Agace WW, Roberts AI,Wu L, Greineder C, Ebert EC, Parker CM. Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation. Eur J Immunol 2000; 30:819-26.
14. Dwinell MB, Lugering N, Eckmann L, Kagnoff MF. Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells. Gastroenterology 2001; 120:49-59.
15. Grimm MC, Elsbury SK, Pavli P, Doe WF. Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa. J Leukoc Biol 1996; 59:804-12.
16. Combadiere C, Ahuja SK, Murphy PM. Cloning and functional expression of a human eosinophil CC chemokine receptor. J Biol Chem 1995; 270:16491-4.
17. Uguccioni M,Mackay CR, Ochensberger B et al.High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest 1997; 100:1137-43.
18. Rubbert A, Combadiere C, Ostrowski M et al. Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry. J Immunol 1998; 160:3933-41.
19. Sallusto F,Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997; 277:2005-7.
20. Erin EM, Williams TJ, Barnes PJ, Hansel TT. Eotaxin receptor (CCR3) antagonism in asthma and allergic disease. Curr Drug Targets Inflamm Allergy 2002; 1:201-14.
21. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989; 170:2-6.
22. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70:439-44.
23. Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut 1998; 43:29-32.
24. Papadaki HA, Stamatopoulos K, Damianaki A et al. Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia. Br J Haematol 2005; 128:863-76.
25. Jordan NJ, Kolios G, Abbot SE et al. Expression of functional cxcr4 chemokine receptors on human colonic epithelial cells. J Clin Invest 1999; 104:1061-9.
26. Valatas V, Kolios G,Manousou P et al. Octreotide regulates CC but not CXC LPS-induced chemokine secretion in rat Kupffer cells. Br J Pharmacol 2004; 141:477-87.
27. Jump RL, Levine AD.Mechanisms of natural tolerance in the intestine: implications for inflammatory bowel disease. Inflamm Bowel Dis 2004; 10:462-78.
28. Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 2000; 51:289-98.
29. Monteleone G, Fina D, Caruso R, Pallone F. New mediators of immunity and inflammation in inflammatory bowel disease. Curr Opin Gastroenterol 2006; 22:361-4.
30. Ince MN, Elliott DE. Immunologic and molecular mechanisms in inflammatory bowel disease. Surg Clin North Am 2007; 87:681-96.
31. Boirivant M, Fuss IJ, Chu A, Strober W. Oxazolone colitis: amurine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med 1998; 188:1929-39.
32. Parronchi P, Romagnani P, Annunziato F et al. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol 1997; 150:823-32.
33. Kobayashi T, Okamoto S, Hisamatsu T et al. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut 2008; 57:1682-9.
34. Abraham C, Cho JH. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease. Annu Rev Med 2009; 60:97-110.
35. Shibahara T, Si-Tahar M, Shaw SK,Madara JL. Adhesionmolecules expressed on homing lymphocytes in model intestinal epithelia. Gastroenterology 2000; 118:289-98.
36. Gerber BO, Zanni MP,UguccioniMet al. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr Biol 1997; 7:836-43.
37. Berrebi D, Languepin J, Ferkdadji L et al. Cytokines, chemokine receptors, and homing molecule distribution in the rectum and stomach of pediatric patients with ulcerative colitis. J Pediatr Gastroenterol Nutr 2003; 37:300-8.
38. Jo Y,Matsumoto T, Yada S et al. CCR4 is an up-regulated chemokine receptor of peripheral blood memory CD4+ T cells in Crohn's disease. Clin Exp Immunol 2003; 132:332-8.
39. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996; 2:449-56.
40. Chen W, Paulus B, Shu D, Wilson, Chadwick V. Increased serum levels of eotaxin in patients with inflammatory bowel disease. Scand J Gastroenterol 2001; 36:515-20.
41. Mir A, Minguez M, Tatay J et al. Elevated serum eotaxin levels in patients with inflammatory bowel disease. Am J Gastroenterol 2002; 97:1452-7.
42. Kolios G, Wright KL, Jordan NJ, Leithead JB, Robertson DA, Westwick J. C-X-C and C-C chemokine expression and secretion by the human colonic epithelial cell line, HT-29: differential effect of T lymphocyte-derived cytokines. Eur J Immunol 1999; 29:530-6.
43. Kucharzik T, Hudson JT, III, Lugering A et al. Acute induction of human IL-8 production by intestinal epithelium triggers neutrophil infiltration without mucosal injury. Gut 2005; 54:1565-72.
44. Manousou P, Kolios G, Drygiannakis I et al. Expression of a splice variant of CXCR3 in Crohn's disease patients; Indication for a lymphocyte-epithelial cell interaction. J Gastroenterol Hepatol 2008; 23:1823-33.
45. Ruth JH, Lukacs NW, Warmington KS et al. Expression and participation of eotaxin during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granuloma formation. J Immunol 1998; 161:4276-82.